Medicine's Reshmi Parameswaran studies new therapy for bone cancer in children

Promising new therapy developed for most common form of bone cancer in children and young adults

Medical Xpress: Reshmi Parameswaran, associate professor at the School of Medicine and member of the Immune Oncology Program at the Case Comprehensive Cancer Center, explained how conventional therapies for osteosarcoma, which consist of chemotherapy and surgery, have not changed much in the last 40 years. "Our new approach offers the possibility of a targeted treatment that harnesses the body's own immune system to fight the cancer—potentially offering better outcomes with fewer side effects than traditional chemotherapy," said Parameswaran.